Abiopharma

🔍 Quincey James (Director)

Company: COCA COLA CO (KO)

Report Date: 2026-07-28

Detailed Transactions and Holdings:

• Acquired 381,140 shares of Common Stock, $.25 Par Value at $45.435 per share (Direct)
  Date: 2026-07-28 | Code: M | equity_swap_involved: 0 | shares_owned_after: 503,973.00 | transaction_form_type: 4
• Sold 381,140 shares of Common Stock, $.25 Par Value at $90.0447 per share (Direct)
  Date: 2026-07-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 122,833.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 145,947 shares of Common Stock, $.25 Par Value at $45.435 per share (Direct)
  Date: 2026-07-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 268,780.00 | transaction_form_type: 4
• Sold 145,947 shares of Common Stock, $.25 Par Value at $90.0942 per share (Direct)
  Date: 2026-07-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 122,833.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Holds 0 shares of Common Stock, $.25 Par Value (Direct)
  Date: 2026-07-28 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 9,101.00 | Footnotes: F4
• Sold 381,140 shares of Employee Stock Option (Right to Buy) at $45.435 per share (Derivative)
  Date: 2026-07-28 | Code: M | Expires: 2029-02-21 | equity_swap_involved: 0 | shares_owned_after: 145,947.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 145,947 shares of Employee Stock Option (Right to Buy) at $45.435 per share (Derivative)
  Date: 2026-07-29 | Code: M | Expires: 2029-02-21 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F5
• Holds 38,392 shares of Hypothetical Shares (Derivative)
  Date: 2026-07-28 | Code: H | shares_owned_after: 38,392.00 | Footnotes: F6, F7, F7, F8

Footnotes:

• F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on March 5, 2026.
• F2: The price is the weighted average sale price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.21. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
• F3: The price is the weighted average sale price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.26. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
• F4: Shares credited to the reporting person's account under The Coca-Cola Company 401(k) Plan, as of July 28, 2026.
• F5: Options (with tax withholding right) granted on February 21, 2019 under The Coca-Cola Company 2014 Equity Plan. One-fourth of grant became exercisable on each of the first, second, third and fourth anniversaries of the grant date.
• F6: Each hypothetical share is equal to one share of common stock of The Coca-Cola Company.
• F7: There is no data applicable with respect to the hypothetical shares.
• F8: As of July 28, 2026.